Artificial intelligence (AI) is embedded in addiction scholarship, not only as a methodological tool in research but also as a tool for manuscript preparation. ...

Background: Opioid use disorder (OUD) is often under-addressed in hospitalized patients. In the absence of formal addiction consult services, volunteer physicia...

Objectives: To characterize state laws targeting patient brokering and deceptive marketing of substance use disorder (SUD) treatment. Background: Patient broke...

Background: Few patient-facing educational materials and interventions exist for the prevention of injection drug use-related infective endocarditis (IDU-IE). W...

Background: Opioid use disorder (OUD) affects millions of individuals each year in the United States. Patient retention in medications for opioid use disorder (...

Background: Treatment for substance use disorders (SUD) remains low in the United States. To better meet needs of people who use alcohol and other drugs, low th...

Subscription and open access journals from Sage, the world's leading independent academic publisher.

AMERSA, founded in 1976, is a non-profit professional organization whose mission is to improve health and well-being through interdisciplinary leadership in substance use education, research, clinical care and policy.

Subscription and open access journals from Sage, the world's leading independent academic publisher.